Head of the Subcellular Pathology and Diagnostics Laboratory, S. Orsola-Malpighi Hospital-University University of Bologna

Giovanna Cenacchi is Associate Professor of Pathological Anatomy at the School of Medicine and Surgery of the Alma Mater University of Bologna. She is the Head of the Subcellular Pathology and Diagnostics Laboratory of the Department of Biomedical and Neurological Sciences, Section of Pathological Anatomy and Head of the Simple Structure “Pathology and Ultracellular Diagnostics” at the Pathological Anatomy Operative Unit, S.Orsola University Hospital Malpighi. The research activity is focused in the neuropathological field on the study of the etiopathogenetic mechanisms of rare and muscular diseases and of high-grade neoplasia of the central nervous system. She is President of the Italian Association of Neuropathology and Clinical Neurobiology, AINPeNC, Coordinator of the Italian Group of Ultrastructural Pathology, GIPU of the Italian Society of Pathological Anatomy, SIAPEC, and Head of the European working group for electron microscopy, EMWG, of the European Society of Pathology, ESP. She is Director of the Summer School “Innovation and technological management of medical and pharmaceutical biotechnologies”. She is the author of 145 publications in international scientific journals with Impact Factor.


The course introduces to the sectors Healthcare and Life science through the presentation and discussion of business and scientific scenarios, highlighting the interrelations and the impact on the industrial and sector structure, the competitive structure and the evolutionary perspectives. The scenario of scientific innovations in the field of Healthcare and Life science is very broad and ranges from innovation in diagnostics to gene therapy, from regenerative medicine (stem cells, tissue engineering and biomaterials) to molecular farming for the creation of biopharmaceuticals in plant . In order for the results of scientific research in life sciences and biomedical technologies to be transformed into usable innovation by citizens and patients, a series of steps are required to enhance the technology, scale-up production, experimentation on patients and preparation of documentation necessary to obtain authorization for sale. It is a complex process that involves many different actors (companies and institutions). In this scenario, the knowledge of the industrial and competitive structure of the sector, of the value chain that integrates the various actors, and of the dynamics that characterize them are fundamental to enable innovation to become a product. The course is completed by identifying the professional profiles and key competences that oversee the path that leads from research to the market in companies and institutions.

Business Management – Life Science and MedTech